News
Despite global decline, rheumatic heart disease persists in poorest regions
From 1990 to 2015, the percentage of deaths worldwide due to rheumatic heart disease rose in endemic regions of Oceania, South Asia, and central...
News
Dermatologists have a role in managing GVHD
NEW YORK – Intralesional and topical steroids, and topical calcineurin inhibitors are among the treatments that can be used to treat GVHD.
Article
Pooled Analysis Clarifies VNS Efficacy in Cluster Headache
BOSTON—Noninvasive vagal nerve stimulation (VNS) is well tolerated and effectively aborts episodic cluster headache attacks, according to a pooled...
News
Studies backing certain FDA approvals found lacking
The quality of studies and data relied upon to support Food and Drug Administration–accelerated drug approvals and high-risk device modifications...
Article
Cannabidiol Changes Serum Levels of Antiepileptic Drugs
The pharmaceutical formulation of cannabidiol (CBD) is associated with significant changes in serum levels of clobazam, rufinamide, topiramate,...
Article
Headache Trajectories Differ Five Years After TBI
BOSTON—Over five years after traumatic brain injury (TBI), a relatively large (24% to 30%) group of individuals experience chronic headache pain...
Article
Model Predicts Outcomes After AED Withdrawal
An evidence-based model allows neurologists to predict individual patient outcomes following the withdrawal of antiepileptic drugs (AEDs),...
Article
Sunny With a Chance of Skin Damage
News
Lessons on using cannabinoids for pediatric epilepsy
DENVER – Dr. Amy Brooks-Kayal and her colleagues at Children’s Hospital Colorado care for about 300 children on cannabinoids for refractory...
Article
Amyopathic Dermatomyositis With Plantar Keratoderma Responding to Methotrexate Therapy
Amyopathic dermatomyositis (ADM) represents a substantial subset of dermatomyositis (DM). Patients with this symptom of the disorder may present...